Insider · CIK 0001273885

BERGER FRANKLIN M

Reports to the SEC for 15 companies · FALLS CHURCH, VA

sec.gov

Transactions

Companies

Filings

CIK

0001273885

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-08	Retension Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+5,636 sh	—	—	5,636
2026-06-18	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−29.6K sh	—	—	0
2026-06-18	AVIRAtea Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+29.6K sh	—	—	536,097
2026-06-18	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+26.7K sh	—	—	26,700
2026-06-18	AVIRAtea Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.7K sh	—	—	37,700
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,600 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,500 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc.U Disposition from Tender	Director	UDisposition from Tender	−89.1K sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,600 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2025-10-09	EPIXESSA Pharma Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−784K sh	—	—	0
2025-06-20	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+29.6K sh	—	—	29,600
2025-06-20	AVIRAtea Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+41.2K sh	—	—	41,200
2025-06-20	AVIRAtea Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+29.6K sh	—	—	506,497
2025-06-20	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−29.6K sh	—	—	0
2025-06-18	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2025-01-16	AVIRAtea Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+10K sh	$3.36	+$33.6K	476,897
2025-01-16	AVIRAtea Pharmaceuticals, Inc.P Purchase	Director	PPurchase	−10K sh	$3.36	−$33.6K	476,897
2025-01-15	AVIRAtea Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+15K sh	$3.19	+$47.9K	466,897
2025-01-15	AVIRAtea Pharmaceuticals, Inc.P Purchase	Director	PPurchase	−15K sh	$3.19	−$47.9K	466,897
2024-12-10	AVIRAtea Pharmaceuticals, Inc.S Sale	Director	SSale	−360K sh	$2.85	−$1.02M	451,897
2024-06-21	AVIRAtea Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+41.2K sh	—	—	41,200
2024-06-21	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+29.6K sh	—	—	29,600
2024-06-20	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2024-06-16	AVIRAtea Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+33.2K sh	—	—	811,503
2024-06-16	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−33.2K sh	—	—	0
2024-03-25	EPIXESSA Pharma Inc. · OptionsA Award	Director	AAward	+50K sh	—	—	50,000
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2024-01-26	Rain Oncology Inc.U Disposition from Tender	Director	UDisposition from Tender	−1.01M sh	—	—	0
2023-11-21	EPIXESSA Pharma Inc.P Purchase	Director	PPurchase	+23.3K sh	$5.73	+$133K	784,404
2023-11-03	EPIXESSA Pharma Inc.P Purchase	Director	PPurchase	+16.5K sh	$5.99	+$98.7K	760,875
2023-11-02	EPIXESSA Pharma Inc.P Purchase	Director	PPurchase	+60K sh	$5.35	+$321K	744,404
2023-08-09	Rain Oncology Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2023-06-16	AVIRAtea Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+46.8K sh	—	—	46,750
2023-06-16	AVIRAtea Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+33.2K sh	—	—	33,150
2023-06-15	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2023-06-13	Atreca, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-12-21	EPIXESSA Pharma Inc.S Sale	Director	SSale	−37.9K sh	$2.41	−$91.3K	718,738
2022-12-21	EPIXESSA Pharma Inc.S Sale	Director	SSale	−34.3K sh	$2.42	−$83.1K	684,404
2022-12-20	EPIXESSA Pharma Inc.S Sale	Director	SSale	−43.6K sh	$2.53	−$110K	756,627
2022-12-16	EPIXESSA Pharma Inc.S Sale	Director	SSale	−50K sh	$2.67	−$134K	800,244
2022-12-15	EPIXESSA Pharma Inc.S Sale	Director	SSale	−50K sh	$2.86	−$143K	850,244
2022-12-15	EPIXESSA Pharma Inc.S Sale	Director	SSale	−32K sh	$2.90	−$92.8K	900,244

Recent filings

Accepted (ET)
Oct 8 21:384
BERGER FRANKLIN M0001213900-26-108188
SEC(opens sec.gov)
Jun 234
BERGER FRANKLIN M0001193125-26-279726
SEC(opens sec.gov)
May 114
BERGER FRANKLIN M0001273885-26-000002
SEC(opens sec.gov)
Oct 154
BERGER FRANKLIN M0001104659-25-099655
SEC(opens sec.gov)
Jun 244
BERGER FRANKLIN M0000950170-25-089606
SEC(opens sec.gov)
Jun 234
BERGER FRANKLIN M0001415889-25-017966
SEC(opens sec.gov)
Jan 174
BERGER FRANKLIN M0000950170-25-006489
SEC(opens sec.gov)
Jan 174/A
BERGER FRANKLIN M0000950170-25-006589
SEC(opens sec.gov)

Companies

Address

1104 WEST BROAD STREET SUITE 1029

FALLS CHURCH, VA, 22046